scispace - formally typeset
J

Joseph M. Zabramski

Researcher at Barrow Neurological Institute

Publications -  124
Citations -  6902

Joseph M. Zabramski is an academic researcher from Barrow Neurological Institute. The author has contributed to research in topics: Aneurysm & Subarachnoid hemorrhage. The author has an hindex of 39, co-authored 124 publications receiving 6330 citations. Previous affiliations of Joseph M. Zabramski include University of California, San Francisco & Case Western Reserve University.

Papers
More filters
Journal ArticleDOI

Cavernous malformations of the brainstem: experience with 100 patients.

TL;DR: The natural history of CMBs is worse than that of cavernous malformations in other locations and can be resected using skull base approaches, which should be considered in patients with symptomatic hemorrhage who harbor lesions that approach the pial surface.
Journal ArticleDOI

Relationship of perfusion pressure and size to risk of hemorrhage from arteriovenous malformations

TL;DR: It is suggested that differences in arterial feeding pressure may be responsible for the observed relationship between the size of AVM's and the frequency and severity of hemorrhage.
Journal ArticleDOI

The Barrow Ruptured Aneurysm Trial: 6-year results

TL;DR: Although BRAT was statistically underpowered to detect small differences, these results suggest little difference in outcome between the 2 treatments for anterior circulation aneurysms, where coil embolization appeared to provide a sustained advantage over clipping.
Journal ArticleDOI

Cavernous malformations of the brain stem. A review of 139 cases.

TL;DR: A retrospective analysis of 139 patients with brain stem cavernous malformations is presented, finding that increase in size was observed in 12 of the patients; this correspondends to about 21% when only patients with a follow-up of at least one year are considered.

Review of 122 cases of spinal cord and vertebral column injuries

TL;DR: The authors conclude that the outcome after pediatric spinal trauma is good, and no patient was made worse by treatment, 89% of the patients with incomplete myelopathy on admission were improved on their last examination, and 20% of those with a completeMyelopathy had evidence of significant recovery of function.